Translational Mini-Review Series on Vaccines for HIV: Harnessing innate immunity for HIV vaccine development.
Innate immunity is critical for shaping vaccine-elicited adaptive immune responses. Several classes of immune sensors, including Toll-like receptors, retinoic acid-inducible gene-I-like receptors, nucleotide-binding oligomerization domain-like receptors and cytosolic DNA receptors mediate important innate immune pathways and provide potential targets for novel adjuvant development. Understanding how innate immunity modulates adaptive immune responses will probably be important for optimizing vaccine candidates. Here, we review recent advances in innate immunity, focusing upon their potential applications in developing adjuvants and vectors for HIV vaccines.
Rhee
E G
EG
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Barouch
D H
DH
D016915:AIDS Vaccines / Q000276:immunology*; D000276:Adjuvants, Immunologic; D015658:HIV Infections / Q000276:immunology* / Q000517:prevention & control*; D015497:HIV-1; D006801:Humans; D007113:Immunity, Innate; D007156:Immunologic Memory; D008024:Ligands; D051193:Toll-Like Receptors / Q000276:immunology
D016915:AIDS Vaccines; D000276:Adjuvants, Immunologic; D008024:Ligands; D051193:Toll-Like Receptors